Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00591162 · ClinicalTrials.gov registry record · Phase 2
Bone Disease in Severely Burned Children
A Phase 2 study, sponsored by The University of Texas Medical Branch, Galveston.
- Terminated
- Registry status
- Phase 2
- Development phase
- 254
- Enrollment target
NCT00591162 is a Phase 2 study that was terminated before completion, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 254 participants.
The verdict
NCT00591162, a Phase 2 study, was terminated before completion, sponsored by The University of Texas Medical Branch, Galveston.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 254 participants
- Enrollment target
Study Summary
Bone metabolism is adversely affected by severe burns in children for a period of time.
Interventions
- DRUG Tetracycline
- RADIATION Duel Energy X-Ray Absorptiometry (DEXA)
- PROCEDURE Bone Biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 254 participants |
| Start Date | 1992-10 |
| Est. Completion | 2008-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00591162
The ClinicalTrials.gov registry entry for NCT00591162 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 254 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Tetracycline is the first listed.
NCT00591162 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00591162 about?
NCT00591162 is a clinical study titled "Bone Disease in Severely Burned Children". Bone metabolism is adversely affected by severe burns in children for a period of time.
What is the current status of trial NCT00591162?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 254 participants. The study started on 1992-10. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00591162?
The interventions under investigation include: Tetracycline (DRUG), Duel Energy X-Ray Absorptiometry (DEXA) (RADIATION), Bone Biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT00591162?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.